| 2026-08-05 | Press release | GRAIL Reports Second Quarter 2026 Financial Results |
| 2026-07-30 | Press release | GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference |
| 2026-07-29 | Press release | GRAIL to Announce Second Quarter 2026 Financial Results |
| 2026-07-16 | Press release | July 16, 2026 Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Canc |
| 2026-06-25 | Press release | June 25, 2026 GRAIL Completes $110 Million Equity Financing With Samsung Entities View Press Release |
| 2026-05-31 | Presentation | GRAIL 2026 ASCO Analyst Call |
| 2026-05-31 | Press release | May 31, 2026 GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantiall |
| 2026-05-30 | Press release | May 30, 2026 GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Di |
| 2026-05-27 | Press release | GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
| 2026-05-26 | Press release | May 26, 2026 GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference View Press Release |
| 2026-05-21 | Press release | May 21, 2026 GRAIL to Present at the 2026 Jefferies Global Healthcare Conference View Press Release |
| Press release | May 5, 2026 GRAIL Reports First Quarter 2026 Financial Results View Press Release |
| 2026-04-30 | Press release | April 30, 2026 GRAIL to Present at the BofA Securities 2026 Health Care Conference View Press Release |
| 2026-04-21 | Press release | April 21, 2026 GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting View Press Releas |
| 2026-04-07 | Press release | April 7, 2026 GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Acc |
| 2026-03-12 | Press release | March 12, 2026 GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor View P |
| 2026-02-24 | Press release | February 24, 2026 GRAIL to Present at the TD Cowen 46th Annual Health Care Conference View Press Release |
| Press release | February 19, 2026 GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results View Press Release |
| 2026-02-19 | Press release | February 19, 2026 Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increase |
| 2026-02-16 | Press release | February 16, 2026 GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results View Press Release |
| 2026-01-29 | Press release | January 29, 2026 GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test Vie |
| 2026-01-12 | Presentation | 44th Annual J.P. Morgan Healthcare Conference |
| 2025-12-15 | Press release | December 15, 2025 GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference View Press Release |
| 2025-11-18 | Press release | November 18, 2025 GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference View Press Release |
| Press release | November 12, 2025 GRAIL Reports Third Quarter 2025 Financial Results View Press Release |
| 2025-11-04 | Press release | November 4, 2025 GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference View Press Release |
| 2025-10-29 | Press release | October 29, 2025 GRAIL to Announce Third Quarter 2025 Financial Results View Press Release |
| 2025-10-20 | Presentation | PATHFINDER 2 Study Results Presented at ESMO 2025 |
| 2025-10-20 | Press release | October 20, 2025 GRAIL, Inc. Announces $325.0 Million Private Placement Financing View Press Release |
| 2025-10-20 | Press release | October 20, 2025 GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri |
| 2025-10-17 | Press release | October 17, 2025 GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Dete |
| 2025-10-16 | Press release | October 16, 2025 Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detecti |
| 2025-09-23 | Press release | September 23, 2025 GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLI |
| 2025-09-10 | Press release | September 10, 2025 GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare For |
| 2025-08-26 | Press release | August 26, 2025 GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference View Press Release |
| Press release | August 12, 2025 GRAIL Reports Second Quarter 2025 Financial Results View Press Release |
| 2025-08-11 | Earnings deck | Q2 2025 Earnings Presentation |
| 2025-07-30 | Press release | July 30, 2025 GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference View Press Release |
| 2025-07-29 | Press release | July 29, 2025 GRAIL to Announce Second Quarter 2025 Financial Results View Press Release |
| 2025-06-18 | Press release | June 18, 2025 GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study View Press R |